Novartis AG Price to Book Ratio 2006-2018 | NVS

Historical price to book ratio values for Novartis AG (NVS) over the last 10 years. The current price to book ratio for Novartis AG as of September 25, 2018 is 2.57.
Novartis AG Annual Price/Book Ratio
Novartis AG Quarterly Price/Book Ratio
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $197.656B $49.109B
Novartis AG is committed to improving health and well-being through innovative products and services. The company aspires to capture and hold a leadership position in all of their businesses with a strong, sustainable performance based on continuous innovation. Their long-term success is founded on meeting the expectations of all our stakeholders - their customers, their people, their shareholders and the communities in which they live and work.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $376.867B 18.01
Pfizer (PFE) United States $261.509B 15.31
Merck (MRK) United States $190.836B 16.85
AbbVie (ABBV) United States $141.463B 13.82
Novo Nordisk (NVO) Denmark $117.216B 18.74
Eli Lilly (LLY) United States $113.402B 20.99
Sanofi (SNY) France $108.851B 13.78
Bristol-Myers Squibb (BMY) United States $100.671B 18.22
GlaxoSmithKline (GSK) United Kingdom $99.693B 13.31
AstraZeneca (AZN) United Kingdom $95.870B 10.54